Artivion, Inc. (AORT)

USD 27.79

(-3.84%)

Total Debt Summary of Artivion, Inc.

  • Artivion, Inc.'s latest annual total debt in 2023 was 359.34 Million USD , up 0.7% from previous year.
  • Artivion, Inc.'s latest quarterly total debt in 2024 Q2 was 362.63 Million USD , up 0.01% from previous quarter.
  • Artivion, Inc. reported annual total debt of 356.82 Million USD in 2022, down -1.44% from previous year.
  • Artivion, Inc. reported annual total debt of 362.04 Million USD in 2021, up 14.07% from previous year.
  • Artivion, Inc. reported quarterly total debt of 362.63 Million USD for 2024 Q2, up 0.01% from previous quarter.
  • Artivion, Inc. reported quarterly total debt of 355.14 Million USD for 2023 Q2, down -0.14% from previous quarter.

Annual Total Debt Chart of Artivion, Inc. (2023 - 1991)

Historical Annual Total Debt of Artivion, Inc. (2023 - 1991)

Year Total Debt Total Debt Growth
2023 359.34 Million USD 0.7%
2022 356.82 Million USD -1.44%
2021 362.04 Million USD 14.07%
2020 317.37 Million USD 29.46%
2019 245.15 Million USD 9.66%
2018 223.54 Million USD -1.25%
2017 226.38 Million USD 216.3%
2016 71.57 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD -100.0%
2009 315 Thousand USD 0.0%
2008 315 Thousand USD -93.2%
2007 4.63 Million USD -0.88%
2006 4.67 Million USD -8.12%
2005 5.08 Million USD 174.96%
2004 1.84 Million USD -25.71%
2003 2.48 Million USD -71.52%
2002 8.74 Million USD -43.03%
2001 15.34 Million USD 17.91%
2000 13.01 Million USD 95.85%
1999 6.64 Million USD -8.99%
1998 7.3 Million USD -60.33%
1997 18.4 Million USD 557.14%
1996 2.8 Million USD 0.0%
1995 - USD 0.0%
1994 - USD 0.0%
1993 - USD -100.0%
1992 2.1 Million USD 50.0%
1991 1.4 Million USD 0.0%

Peer Total Debt Comparison of Artivion, Inc.

Name Total Debt Total Debt Difference
Abbott Laboratories 15.87 Billion USD 97.736%
Allurion Technologies Inc. 41.85 Million USD -758.497%
Avanos Medical, Inc. 209.1 Million USD -71.851%
Butterfly Network, Inc. 25.02 Million USD -1335.813%
Butterfly Network, Inc. 25.02 Million USD -1335.813%
Bio-Rad Laboratories, Inc. 1.4 Billion USD 74.44%
Boston Scientific Corporation 9.49 Billion USD 96.214%
Perspective Therapeutics, Inc. - USD -Infinity%
CONMED Corporation 991.25 Million USD 63.749%
Edwards Lifesciences Corporation 694.9 Million USD 48.289%
Paragon 28, Inc. 112.03 Million USD -220.754%
Glaukos Corporation 383.73 Million USD 6.358%
Globus Medical, Inc. 520.4 Million USD 30.95%
Inspire Medical Systems, Inc. 24.84 Million USD -1346.273%
Integer Holdings Corporation 1.04 Billion USD 65.48%
Medtronic plc 26.04 Billion USD 98.62%
Nevro Corp. 221.82 Million USD -61.992%
Owlet, Inc. 15.21 Million USD -2261.6%
Penumbra, Inc. 234.34 Million USD -53.34%
Vicarious Surgical Inc. 14.83 Million USD -2322.741%
Smith & Nephew plc 3.08 Billion USD 88.348%
Sonendo, Inc. 40.35 Million USD -790.538%
STERIS plc 3.38 Billion USD 89.379%
Stryker Corporation 12.99 Billion USD 97.235%
Vapotherm, Inc. 112.39 Million USD -219.721%
Zimmer Biomet Holdings, Inc. 5.99 Billion USD 94.006%